Direkt zum Inhalt
Merck
  • Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments.

Novel multispecific heterodimeric antibody format allowing modular assembly of variable domain fragments.

mAbs (2016-10-28)
Timothy J Egan, Dania Diem, Richard Weldon, Tessa Neumann, Sebastian Meyer, David M Urech
ZUSAMMENFASSUNG

Multispecific antibody formats provide a promising platform for the development of novel therapeutic concepts that could facilitate the generation of safer, more effective pharmaceuticals. However, the production and use of such antibody-based multispecifics is often made complicated by: 1) the instability of the antibody fragments of which they consist, 2) undesired inter-subunit associations, and 3) the need to include recombinant heterodimerization domains that confer distribution-impairing bulk or enhance immunogenicity. In this paper, we describe a broadly-applicable method for the stabilization of human or humanized antibody Fv fragments that entails replacing framework region IV of a Vκ1/VH3-consensus Fv framework with the corresponding germ-line sequence of a λ-type VL chain. We then used this stable Fv framework to generate a novel heterodimeric multispecific antibody format that assembles by cognate VL/VH associations between 2 split variable domains in the core of the complex. This format, termed multispecific antibody-based therapeutics by cognate heterodimerization (MATCH), can be applied to produce homogeneous and highly stable antibody-derived molecules that simultaneously bind 4 distinct antigens. The heterodimeric design of the MATCH format allows efficient in-format screening of binding domain combinations that result in maximal cooperative activity.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Protein-Standardmischung 15–600 kDa, for size exclusion chromatography
Preise und Verfügbarkeit sind derzeit nicht verfügbar.